Adcendo ApS (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- November 25, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $135,000,000
Company Info
- Company Description
- Adcendo ApS is a biotechnology company focused on developing first-in-class antibody-drug conjugates (ADCs) for the treatment of cancer. The company aims to advance its innovative ADC pipeline to provide effective therapies for patients with unmet medical needs.
- Market
- Pharmaceuticals
- Location
- Denmark